To evaluate the effectiveness, safety, and tolerability of a 12-month treatment with low doses of methadone (MT) (mean MT dosage 12.3 mg ± SD 7.3) as prophylaxis in patients affected by daily refractory headache and medication-overuse headache.
Prophylaxis with low-dose methadone in patients affected by daily refractory headache and medication-overuse headache: a prospective cohort study (METACEF study) / Lupi, Chiara; Pracucci, Chiara; Cesaris, Francesco De; Rossi, Eleonora; Geppetti, Pierangelo; Benemei, Silvia; Galli, Valentina; Occupati, Brunella; Mazzucco, Viola; Mannaioni, Guido. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2377. - ELETTRONICO. - (2015), pp. 118-118.
Prophylaxis with low-dose methadone in patients affected by daily refractory headache and medication-overuse headache: a prospective cohort study (METACEF study)
GEPPETTI, PIERANGELO;BENEMEI, SILVIA;MANNAIONI, GUIDO
2015
Abstract
To evaluate the effectiveness, safety, and tolerability of a 12-month treatment with low doses of methadone (MT) (mean MT dosage 12.3 mg ± SD 7.3) as prophylaxis in patients affected by daily refractory headache and medication-overuse headache.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



